查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654229

兽医肿瘤诊断市场规模、份额、趋势分析报告（动物类型、检测类型、癌症类型、最终用途、地区、细分预测，2025-2030 年）

Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽医肿瘤诊断市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球兽医癌症诊断市场预计到2030年将达到34.5亿美元，2025年至2030年期间的复合年增长率为8.4%。

这个市场的主要驱动因素是动物数量和圈养率的增加、动物支出的增加、重点转向预防性动物保健、兽医癌症诊断测试​​的进步以及对动物健康诊断的研发投资增加以推出创新产品。例如，2024年12月，Pet Preferred Diagnostics宣布了一项针对狗和猫的突破性早期癌症诊断测试​​，该测试可检测与21种肿瘤和14种神经系统疾病相关的11种特异性肿瘤抗体。这种高度敏感的血清学检测通常可以在临床症状出现之前发现恶性肿瘤，从而实现早期治疗。该测试是兽医学中唯一可以区分一系列肿瘤和神经系统疾病的测试，并且是非侵入性的、价格合理的，并且可以在 24 小时内提供快速解决方案并得出结果。

此外，先进的兽医癌症诊断测试​​的开发，例如 Oncotect 推出的世界上第一个也是唯一一个家庭癌症筛检测试，为兽医癌症诊断市场创造了有利可图的机会。这项革命性的犬癌症筛检测试能够更早发现，改善治疗效果并让饲主安心。 Oncotect 可侦测四种最常见的犬癌症，可在家中或诊所使用，方便使用者使用且易于使用。居家检测解决方案的兴起，加上支持其准确性和可近性的提高的临床资料（尤其是对于宠物饲主），正在扩大兽医癌症诊断市场。

此外，宠物癌症发生率的上升也大大推动了兽医癌症诊断市场的成长。根据兽医癌症协会统计，癌症是导致狗死亡的主要原因，尤其是 10 岁以上的狗，占狗死亡的 47%，占猫死亡的 32%。大约四分之一的狗在其一生中会出现异常组织生长或肿瘤。由于宠物身上存在近 100 种不同类型的癌症，诊断起来可能非常困难，但兽医的进步正在提高狗和猫的治疗成功率。根据澳洲研究资料共享中心 (ARDC) 2024 年 5 月的一项研究，澳洲四分之一的狗和五分之一的猫受到影响。根据《癌症快报》报道，预计 2024 年美国将有约 600 万隻宠物狗被诊断出患有癌症，这为改善宠物和人类的癌症诊断创造了独特的机会。此外，美国兽医协会指出，四分之一的狗最终会罹患肿瘤，大约一半的 10 岁以上的狗会罹患癌症。

兽医癌症诊断市场报告重点

  • 根据测试类型，切片检查部分在 2024 年占据市场主导地位，份额为 32.08%。然而，由于兽医癌症诊断检测套组的技术进步，基因组检测领域预计在预测期内以 9.48% 的最快复合年增长率增长。
  • 根据动物类型，由于狗癌症数量的增加和用于狗癌症诊断的产品数量众多，狗将在 2024 年占据最大的市场占有率。由于全球猫科动物数量的增加和相关疾病的显着增加，预计 2025 年至 2030 年间猫科动物市场将以最快的速度增长。
  • 根据癌症类型，皮肤癌预计将在 2024 年占据最高的市场占有率，由于狗和猫中鳞状细胞癌和皮肤肿瘤的盛行率不断上升，复合年增长率最快，为 8.56%。
  • 根据最终用途，由于对诊断的需求不断增加，且医院可以轻鬆获得先进的兽医癌症诊断技术，兽医医院和诊所部门预计将在 2024 年占据最高的市场份额。预计未来几年该领域的复合年增长率将最快。
  • 按地区划分，预计北美将在 2024 年占据最大份额，达到 53.9%，未来几年增长率最快，达到 8.6%。
  • 随着创新液态切片和先进的多癌症诊断技术的发展，兽医癌症诊断检测套组变得更加准确、易于使用和具有成本效益。预计这些进步将推动市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章兽医肿瘤诊断市场的趋势与范围

  • 市场展望
    • 母市场
    • 补贴市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 兽医肿瘤诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析
    • 法律规范
    • 主要国家及动物种类数量预估（2018-2024）
    • COVID-19影响分析

第 4 章兽医肿瘤诊断市场：动物物种估计与趋势分析

  • 细分仪表板
  • 兽医肿瘤诊断市场分析（按动物类型）
  • 2018 年至 2030 年兽医肿瘤诊断市场规模及趋势分析（依动物类型）
    • 狗
    • 猫
    • 其他的

第 5 章兽医肿瘤诊断市场：测试类型估计和趋势分析

  • 细分仪表板
  • 兽医肿瘤诊断市场测试类型变化分析
  • 2018 年至 2030 年兽医肿瘤诊断市场规模及趋势分析（依检测类型）
    • 血液检查
    • 切片检查
    • 基因组检测
    • 内视镜检查
    • 尿液检查
    • 影像

第六章兽医肿瘤诊断市场：癌症类型估计与趋势分析

  • 细分仪表板
  • 兽医肿瘤诊断市场癌症类型变异分析
  • 2018 年至 2030 年兽医肿瘤诊断市场规模及趋势分析（依癌症类型）
    • 淋巴瘤
    • 肉瘤
    • 乳腺肿瘤
    • 皮肤癌
    • 其他的

第 7 章兽医肿瘤诊断市场：最终用途估计与趋势分析

  • 细分仪表板
  • 兽医肿瘤诊断市场最终用途变化分析
  • 2018 年至 2030 年兽医肿瘤诊断市场规模和趋势分析（按最终用途）
    • 参考实验室
    • 兽医诊所和诊所

第 8 章 兽医肿瘤诊断市场：国家估计与趋势分析

  • 区域控制面板
  • 2023 年和 2030 年兽医肿瘤诊断市场占有率（按地区）
  • 区域展望
  • 北美洲
    • 美国
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 市场参与企业分类
  • Participants Overview
  • 财务表现
  • 产品基准
  • 2024 年市场分析（热图分析）
  • 战略地图
    • 合併和收购
    • 推出
    • 伙伴关係和合作
    • 扩张
    • 其他的
  • 公司简介
    • Zoetis
    • Antech Diagnostics, Inc.（Mars Inc.）
    • IDEXX Laboratories, Inc.
    • Neogen Corporation
    • Gold Standard Diagnostics（Eurofins Technologies）
    • Embark Veterinary, Inc.
    • VolitionRx Limited
    • CANCAN DIAGNOSTICS
    • Oncotect
    • PetDx
  • List of Other Market Players

第十章 重点

Product Code: GVR-4-68040-497-2

Veterinary Oncology Diagnostics Market Growth & Trends:

The global veterinary oncology diagnostics market is expected to reach USD 3.45 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, shifting focus on preventative animal healthcare, advances in veterinary cancer diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in December 2024, Pet Preferred Diagnostics introduced a groundbreaking early cancer diagnostic test for dogs and cats that detects 11 specific onconeural antibodies linked to 21 types of tumors and 14 neurological diseases. This highly sensitive serological test can identify malignancy, often before clinical signs appear, enabling early treatment. It is the only test available in veterinary medicine that differentiates various tumors and neurological conditions, offering a non-invasive, affordable, and quick solution with a 24-hour turnaround.

Additionally, the development of advanced veterinary cancer diagnostic tests, such as the world's first and only at-home cancer screening test by Oncotect, is creating lucrative opportunities in the veterinary oncology diagnostics market. This innovative canine cancer screening test enables early detection, improving treatment outcomes and offering peace of mind to pet owners. Oncotect, which detects the four most prevalent types of canine cancer, can be used at home or in-clinic, making it user-friendly and accessible. The rise in at-home testing solutions, coupled with clinical data supporting its accuracy, is expanding the market for veterinary oncology diagnostics, particularly by increasing accessibility for pet parents.

Furthermore, the increasing prevalence of cancer in pets is significantly driving the growth of the veterinary oncology diagnostics market. As per The Veterinary Cancer Society, Cancer is the top reason of death in 47% of canines, particularly those over 10 years old, and in 32% of felines. Around 1 in 4 dogs will experience abnormal tissue growth, or neoplasia, during their lifetime. With nearly 100 types of cancer affecting pets, a diagnosis can be overwhelming, yet advances in veterinary care have improved treatment success rates for both dogs and cats. Similarly, cancer is the leading cause of death in cats and dogs, affecting one in four dogs and one in five cats in Australia, according to a May 2024 study by the Australian Research Data Commons (ARDC). In the U.S., about 6 million pet dogs are expected to be diagnosed with cancer in 2024, creating a unique opportunity to improve cancer diagnosis for both pets and humans, as reported by The Cancer Letter Inc. Additionally, the American Veterinary Association states that one in four dogs will develop neoplasia at some point, and about half of dogs over the age of 10 will develop cancer.

Veterinary Oncology Diagnostics Market Report Highlights:

  • By test type, the biopsy segment dominated the market with a share of 32.08% in 2024. However, the genome testing segment is expected to grow at the fastest CAGR of 9.48% during the forecast period due to technological advancements in veterinary cancer diagnostic test kits.
  • In terms of animal type, the canine segment attributed to the largest market share in 2024 due to the increase in the dog cancer population and the availability of a huge number of products for canine cancer diagnosis. The feline segment is projected to grow at the fastest rate from 2025 to 2030, owing to the rising population of cats worldwide and the apparent rise in the number of associated diseases.
  • In terms of cancer type, the skin cancers segment accounted for the highest market share in 2024 and is expected to grow at the fastest CAGR of 8.56% owing to the rising prevalence of squamous cell carcinoma and skin tumors in cats and dogs.
  • By end use, the veterinary hospitals and clinics segment held the highest share of the market in 2024 owing to the increasing demand for diagnostics and readily accessible advanced veterinary cancer diagnostic technologies in hospitals. This segment is estimated to grow at the fastest CAGR in the coming years.
  • By region, North America had the largest share, 53.9%, of the market in 2024 and is anticipated to grow the fastest, at 8.6%, in the coming years.
  • Advances in innovative liquid biopsy and advanced multi-cancer diagnostic technology have led to the development of more accurate, user-friendly, and cost-effective veterinary oncology diagnostic test kits. Such advancements are expected to drive market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Oncology Diagnostics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cancer in pets
      • 3.2.1.2. Increasing R&D in veterinary oncolgy diagnostics
      • 3.2.1.3. Growing focus on animal safety
      • 3.2.1.4. Growing uptake of pet insurance
      • 3.2.1.5. Technological advancements in early pet cancer diagnosis
      • 3.2.1.6. Increase in pet population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of veterinary oncology diagnostics
      • 3.2.2.2. Lack of awareness in developing countries
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Oncology Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2024
    • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Oncology Diagnostics Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Oncology Diagnostics Market Animal Type Movement Analysis
  • 4.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
    • 4.3.1. Canine
      • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Feline
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Others
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Veterinary Oncology Diagnostics Market: Test Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Oncology Diagnostics Market Test Type Movement Analysis
  • 5.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Test Type 2018 - 2030 (USD Million)
    • 5.3.1. Blood Tests
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Biopsy
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Genome testing
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Endoscopy
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Urinalysis
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.6. Imaging
      • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Veterinary Oncology Diagnostics Market: Cancer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Oncology Diagnostics Market Cancer Type Movement Analysis
  • 6.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
    • 6.3.1. Lymphoma
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Sarcomas
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mammary Gland Tumors
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Skin Cancers
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Others
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Veterinary Oncology Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Oncology Diagnostics Market End-Use Movement Analysis
  • 7.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By End-Use 2018 - 2030 (USD Million)
    • 7.3.1. Reference Laboratories
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Veterinary hospitals and clinics
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Veterinary Oncology Diagnostics Market: Country Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Oncology Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competition Insights
      • 8.4.2.3. U.S. Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million) 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competition Insights
      • 8.4.3.3. Canada Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competition Insights
      • 8.4.4.3. Mexico Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competition Insights
      • 8.5.2.3. UK Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competition Insights
      • 8.5.3.3. Germany Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competition Insights
      • 8.5.4.3. France Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competition Insights
      • 8.5.5.3. Italy Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competition Insights
      • 8.5.6.3. Spain Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competition Insights
      • 8.5.7.3. Denmark Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competition Insights
      • 8.5.8.3. Sweden Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competition Insights
      • 8.5.9.3. Norway Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competition Insights
      • 8.6.2.3. Japan Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competition Insights
      • 8.6.3.3. China Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competition Insights
      • 8.6.4.3. India Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competition Insights
      • 8.6.5.3. Australia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competition Insights
      • 8.6.6.3. South Korea Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competition Insights
      • 8.6.7.3. Thailand Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competition Insights
      • 8.7.2.3. Brazil Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competition Insights
      • 8.7.3.3. Argentina Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competition Insights
      • 8.8.2.3. South Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competition Insights
      • 8.8.3.3. Saudi Arabia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competition Insights
      • 8.8.4.3. UAE Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competition Insights
      • 8.8.5.3. Kuwait Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Participants Overview
  • 9.3. Financial Performance
  • 9.4. Product Benchmarking
  • 9.5. Market Position Analysis, 2024 (Heat Map Analysis)
  • 9.6. Strategy Mapping
    • 9.6.1. MERGERS AND ACQUISITIONS
    • 9.6.2. LAUNCH
    • 9.6.3. PARTNERSHIPS & COLLABORATIONS
    • 9.6.4. EXPANSION
    • 9.6.5. OTHERS
  • 9.7. Company Profiles
    • 9.7.1. Zoetis
      • 9.7.1.1. Participant's overview
      • 9.7.1.2. Financial performance
      • 9.7.1.3. Product Benchmarking
      • 9.7.1.4. Strategic initiatives
    • 9.7.2. Antech Diagnostics, Inc. (Mars Inc.)
      • 9.7.2.1. Participant's overview
      • 9.7.2.2. Financial performance
      • 9.7.2.3. Product Benchmarking
      • 9.7.2.4. Strategic initiatives
    • 9.7.3. IDEXX Laboratories, Inc.
      • 9.7.3.1. Participant's overview
      • 9.7.3.2. Financial performance
      • 9.7.3.3. Product Benchmarking
      • 9.7.3.4. Strategic initiatives
    • 9.7.4. Neogen Corporation
      • 9.7.4.1. Participant's overview
      • 9.7.4.2. Financial performance
      • 9.7.4.3. Product Benchmarking
      • 9.7.4.4. Strategic initiatives
    • 9.7.5. Gold Standard Diagnostics (Eurofins Technologies)
      • 9.7.5.1. Participant's overview
      • 9.7.5.2. Financial performance
      • 9.7.5.3. Product Benchmarking
      • 9.7.5.4. Strategic initiatives
    • 9.7.6. Embark Veterinary, Inc.
      • 9.7.6.1. Participant's overview
      • 9.7.6.2. Financial performance
      • 9.7.6.3. Product Benchmarking
      • 9.7.6.4. Strategic initiatives
    • 9.7.7. VolitionRx Limited
      • 9.7.7.1. Participant's overview
      • 9.7.7.2. Financial performance
      • 9.7.7.3. Product Benchmarking
      • 9.7.7.4. Strategic initiatives
    • 9.7.8. CANCAN DIAGNOSTICS
      • 9.7.8.1. Participant's overview
      • 9.7.8.2. Financial performance
      • 9.7.8.3. Product Benchmarking
      • 9.7.8.4. Strategic initiatives
    • 9.7.9. Oncotect
      • 9.7.9.1. Participant's overview
      • 9.7.9.2. Financial performance
      • 9.7.9.3. Product Benchmarking
      • 9.7.9.4. Strategic initiatives
    • 9.7.10. PetDx
      • 9.7.10.1. Participant's overview
      • 9.7.10.2. Financial performance
      • 9.7.10.3. Product Benchmarking
      • 9.7.10.4. Strategic initiatives
  • 9.8. List of Other Market Players

Chapter 10. Key Takeaways

List of Tables

  • Tables 1 List of Secondary Sources
  • Tables 2 List of Abbreviations
  • Tables 3 Global Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
  • Tables 4 Global Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 5 Global Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Tables 6 Global Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 7 North America Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD
  • Tables 8 North America Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
  • Tables 9 North America Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 10 North America Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Tables 11 North America Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 12 U.S Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
  • Tables 13 U.S Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 14 U.S Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Tables 15 U.S Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 16 Canada Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
  • Tables 17 Canada Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 18 Canada Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Tables 19 Canada Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 20 Mexico Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
  • Tables 21 Mexico Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 22 Mexico Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Tables 23 Mexico Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 24 Europe Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Tables 25 Europe Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 26 Europe Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 27 Europe Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 28 Europe Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 29 Germany Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 30 Germany Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 31 Germany Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 32 Germany Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 33 U.K Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 34 U.K Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 35 UK Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 36 UK Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 37 France Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 38 France Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 39 France Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 40 France Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 41 Italy Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 42 Italy Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 43 Italy Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 44 Italy Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 45 Spain Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 46 Spain Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 47 Spain Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 48 Spain Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 49 Sweden Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 50 Sweden Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 51 Sweden Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 52 Sweden Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 53 Denmark Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 54 Denmark Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 55 Denmark Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 56 Denmark Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 57 Norway Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 58 Norway Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 59 Norway Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 60 Norway Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 61 Asia Pacific Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Tables 62 Asia Pacific Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 63 Asia Pacific Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 64 Asia Pacific Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 65 Asia Pacific Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 66 Japan Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 67 Japan Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 68 Japan Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 69 Japan Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 70 China Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 71 China Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 72 China Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 73 China Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 74 India Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 75 India Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 76 India Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 77 India Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 78 Australia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 79 Australia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 80 Australia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 81 Australia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 82 South Korea Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 83 South Korea Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 84 South Korea Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 85 South Korea Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 86 Thailand Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 87 Thailand Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 88 Thailand Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 89 Thailand Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 90 LATAM Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Tables 91 LATAM Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 92 LATAM Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 93 LATAM Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 94 LATAM Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 95 Brazil Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 96 Brazil Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 97 Brazil Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 98 Brazil Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 99 Argentina Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 100 Argentina Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 101 Argentina Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 102 Argentina Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 103 MEA Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Tables 104 MEA Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 105 MEA Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 106 MEA Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 107 MEA Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 108 South Africa Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 109 South Africa Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 110 South Africa Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 111 South Africa Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 112 Saudi Arabia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 113 Saudi Arabia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 114 Saudi Arabia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 115 Saudi Arabia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 116 UAE Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 117 UAE Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 118 UAE Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 119 UAE Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 120 Kuwait Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Tables 121 Kuwait Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
  • Tables 122 Kuwait Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
  • Tables 123 Kuwait Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
  • Tables 124 Company Overview
  • Tables 125 Service Benchmarking
  • Tables 126 Financial Performance
  • Tables 127 Strategic Initiatives

List of Figures

  • Fig. 1 Global Veterinary Oncology Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data Analysis Models
  • Fig. 6 Market Formulation And Validation
  • Fig. 7 Data Validating & Publishing
  • Fig. 8 General methodology for a commodity flow analysis of Global Veterinary Oncology Diagnostics Market
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Parent market analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market value, 2024 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2024
  • Fig. 17 Global Veterinary Oncology Diagnostics Market Dynamics
  • Fig. 18 Estimated animal population, 2018-2024 by key species and key countries
  • Fig. 19 Global Veterinary Oncology Diagnostics Market: PORTER's analysis
  • Fig. 20 Global Veterinary Oncology Diagnostics Market: PESTEL analysis
  • Fig. 21 Global Veterinary Oncology Diagnostics Market by Animal: Key Takeaways
  • Fig. 22 Global Veterinary Oncology Diagnostics Market by Animal, 2024 & 2030
  • Fig. 23 Canine market, 2018 - 2030 (USD Million)
  • Fig. 24 Feline market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Veterinary Oncology Diagnostics Market by Test Type: Key Takeaways
  • Fig. 27 Global Veterinary Oncology Diagnostics Market by Test Type, Market Share, 2024 & 2030
  • Fig. 28 Blood Tests market, 2018 - 2030 (USD Million)
  • Fig. 29 Biopsy market, 2018 - 2030 (USD Million)
  • Fig. 30 Genome testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Endoscopy market, 2018 - 2030 (USD Million)
  • Fig. 32 Urinalysis market, 2018 - 2030 (USD Million)
  • Fig. 33 Imaging market, 2018 - 2030 (USD Million)
  • Fig. 34 Global Veterinary Oncology Diagnostics Market by Cancer Type: Key Takeaways
  • Fig. 35 Global Veterinary Oncology Diagnostics Market by Cancer Type, Market Share, 2024 & 2030
  • Fig. 36 Lymphoma market, 2018 - 2030 (USD Million)
  • Fig. 37 Sarcomas market, 2018 - 2030 (USD Million)
  • Fig. 38 Mammary Gland Tumors market, 2018 - 2030 (USD Million)
  • Fig. 39 Skin Cancers market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Global Veterinary Oncology Diagnostics Market by End-Use: Key Takeaways
  • Fig. 42 Global Veterinary Oncology Diagnostics Market by End-Use, Market Share, 2024 & 2030
  • Fig. 43 Reference Laboratories market, 2018 - 2030 (USD Million)
  • Fig. 44 Veterinary hospitals and clinics market, 2018 - 2030 (USD Million)
  • Fig. 45 Regional market share analysis, 2024 & 2030
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Canada Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Mexico Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Sweden Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Denmark Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 China Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 India Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Australia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Korea Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Argentina Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Market Participant Categorization
  • Fig. 99 Heat map analysis
  • Fig. 100 Strategic Framework